Icon
+91 94997 68112
Login Register

Enstilar - (0.005%/0.064%; Aerosol, Foam)

Calcipotriene and Betamethasone Dipropionate Leo Pharma
0.005%/0.064%; Aerosol, Foam
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
 None
Enstilar Foam is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older
Yes
******** ** ***. ******** ***** * **** ** ** ******* '***, '***, '***, '*** , '*** *** *** *********. ** ****** **** **** ******** ****** ** ***** ****. ** *** ****, ******** ******** ***** ********.
Enstilar Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9
******** *** ********* *** ********* *** ********* *** ********* ******* ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******** *** \ *** ***** *, **** ******* ******** ******* *** **** *** *** ****
  1. *** **, **** : ******** ****** *** ****** ***** **'* **** ** ****** ** ******* '***, '***, '***, '*** *** '***
  2. *** *, **** : *** ****** ***** * **** ******* ******** ** ******* '***, '***, '***, '*** *** '***
  3. *** **, **** : *** ****** ******* **** ******** ** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.